NF-κB Signaling Pathway Inhibition (NF-κB Inhibition)

Inhibition of the NF-κB signaling pathway, a central regulator of inflammation, immunity, and cell survival, is achieved through various strategies targeting key components like IκB kinases (IKKs) or the NF-κB transcription factors themselves. This approach aims to modulate gene expression involved in inflammation, immune responses, cell proliferation, and apoptosis, offering therapeutic potential for a wide range of diseases including cancer, autoimmune disorders, and neurodegenerative conditions.

Other names

NF-kB Pathway BlockadeNF-κB Signaling Suppression

Inhibition of NF-κB signaling pathway components such as IKK or direct interference with NF-κB binding to DNA, leading to reduced expression of pro-inflammatory genes and modulation of cell survival.